{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:58:09Z","timestamp":1791086289849,"version":"4.1.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>Bone and mineral disorders occur frequently in kidney transplant recipients and are associated with a high risk of fracture, morbidity, and mortality. There is a broad spectrum of often overlapping bone diseases seen after transplantation, including osteoporosis as well as persisting high\u2013 or low\u2013turnover bone disease. The pathophysiology underlying bone disorders after transplantation results from a complex interplay of factors, including preexisting renal osteodystrophy and bone loss related to a variety of causes, such as immunosuppression and alterations in the parathyroid hormone-vitamin D-fibroblast growth factor 23 axis as well as changes in mineral metabolism. Management is complex, because noninvasive tools, such as imaging and bone biomarkers, do not have sufficient sensitivity and specificity to detect these abnormalities in bone structure and function, whereas bone biopsy is not a widely available diagnostic tool. In this review, we focus on recent data that highlight improvements in our understanding of the prevalence, pathophysiology, and diagnostic and therapeutic strategies of mineral and bone disorders in kidney transplant recipients.<\/jats:p>","DOI":"10.2215\/cjn.11371015","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T22:18:00Z","timestamp":1455574680000},"page":"1282-1296","source":"Crossref","is-referenced-by-count":129,"title":["Bone Disease after Kidney Transplantation"],"prefix":"10.2215","volume":"11","author":[{"given":"Antoine","family":"Bouquegneau","sequence":"first","affiliation":[{"name":"Department of Nephrology, Dialysis, and Transplantation, Centre Hospitalier Universitaire de Liege, Liege, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syrazah","family":"Salam","sequence":"additional","affiliation":[{"name":"Sheffield Kidney Institute, Northern General Hospital, Sheffield, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Delanaye","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis, and Transplantation, Centre Hospitalier Universitaire de Liege, Liege, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Eastell","sequence":"additional","affiliation":[{"name":"Academic Unit of Bone Metabolism, Metabolic Bone Centre, Northern General Hospital, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Khwaja","sequence":"additional","affiliation":[{"name":"Sheffield Kidney Institute, Northern General Hospital, Sheffield, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"key":"B1-20230816","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/ajt.12652","article-title":"Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States","volume":"14","author":"Sukumaran Nair","year":"2014","journal-title":"Am J Transplant"},{"key":"B2-20230816","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrneph.2009.192","article-title":"Bone disease after renal transplantation","volume":"6","author":"Malluche","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"B3-20230816","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/01.TP.0000131990.13277.28","article-title":"Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation","volume":"77","author":"Brandenburg","year":"2004","journal-title":"Transplantation"},{"key":"B4-20230816","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.01510506","article-title":"Bone disease after renal transplantation","volume":"1","author":"Weisinger","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5-20230816","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1097\/TP.0b013e3181a6bbda","article-title":"Risk of fractures after renal transplantation in the United States","volume":"87","author":"Nikkel","year":"2009","journal-title":"Transplantation"},{"key":"B6-20230816","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/TP.0b013e31828eead8","article-title":"Fracture risk in kidney transplant recipients: A systematic review","volume":"95","author":"Naylor","year":"2013","journal-title":"Transplantation"},{"key":"B7-20230816","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"key":"B8-20230816","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/ki.2012.430","article-title":"Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes","volume":"83","author":"Nikkel","year":"2013","journal-title":"Kidney Int"},{"key":"B9-20230816","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jbmr.2106","article-title":"In vivo assessment of bone quality in postmenopausal women with type 2 diabetes","volume":"29","author":"Farr","year":"2014","journal-title":"J Bone Miner Res"},{"key":"B10-20230816","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1600-6143.2011.03872.x","article-title":"Reduced fracture risk with early corticosteroid withdrawal after kidney transplant","volume":"12","author":"Nikkel","year":"2012","journal-title":"Am J Transplant"},{"key":"B11-20230816","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/ctr.12621","article-title":"Fracture risk and mortality post-kidney transplantation","volume":"29","author":"Ferro","year":"2015","journal-title":"Clin Transplant"},{"key":"B12-20230816","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.V1161093","article-title":"High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation","volume":"11","author":"Monier-Faugere","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"B13-20230816","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"key":"B14-20230816","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/TP.0b013e3182985468","article-title":"Persistence of bone and mineral disorders 2 years after successful kidney transplantation","volume":"96","author":"Neves","year":"2013","journal-title":"Transplantation"},{"key":"B15-20230816","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0272-6386(04)00955-2","article-title":"Histologic evolution of bone disease 6 months after successful kidney transplantation","volume":"44","author":"Cruz","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B16-20230816","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.transproceed.2007.10.001","article-title":"Renal osteodystrophy after successful renal transplantation: A histomorphometric analysis in 57 patients","volume":"39","author":"Lehmann","year":"2007","journal-title":"Transplant Proc"},{"key":"B17-20230816","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"N Engl J Med"},{"key":"B18-20230816","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2013080851","article-title":"Kidney transplantation with early corticosteroid withdrawal: Paradoxical effects at the central and peripheral skeleton","volume":"25","author":"Iyer","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B19-20230816","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/SLA.0000000000001431","article-title":"How well does renal transplantation cure hyperparathyroidism?","volume":"262","author":"Lou","year":"2015","journal-title":"Ann Surg"},{"key":"B20-20230816","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/TP.0000000000000823","article-title":"A prospective cohort study of mineral metabolism after kidney transplantation","volume":"100","author":"Wolf","year":"2016","journal-title":"Transplantation"},{"key":"B21-20230816","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.tp.0000230130.50451.78","article-title":"Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function","volume":"82","author":"Akaberi","year":"2006","journal-title":"Transplantation"},{"key":"B22-20230816","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am J Transplant"},{"key":"B23-20230816","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/ajt.12738","article-title":"Vitamin D in renal transplantation - from biological mechanisms to clinical benefits","volume":"14","author":"McGregor","year":"2014","journal-title":"Am J Transplant"},{"key":"B24-20230816","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/TP.0000000000000055","article-title":"Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients","volume":"98","author":"Lee","year":"2014","journal-title":"Transplantation"},{"key":"B25-20230816","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1681\/ASN.2012060614","article-title":"Vitamin D status and outcomes after renal transplantation","volume":"24","author":"Bienaim\u00e9","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B26-20230816","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1745-6215-10-36","article-title":"VITA-D: Cholecalciferol substitution in vitamin D deficient kidney transplant recipients: A randomized, placebo-controlled study to evaluate the post-transplant outcome","volume":"10","author":"Thiem","year":"2009","journal-title":"Trials"},{"key":"B27-20230816","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1111\/j.1600-6143.2008.02423.x","article-title":"Can DXA predict fractures in renal transplant patients?","volume":"8","author":"Akaberi","year":"2008","journal-title":"Am J Transplant"},{"key":"B28-20230816","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jbmr.2358","article-title":"Longitudinal HR-pQCT and image registration detects endocortical bone loss in kidney transplantation patients","volume":"30","author":"Nishiyama","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B29-20230816","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/01.TP.0000438200.84154.1a","article-title":"FRAX predicts fracture risk in kidney transplant recipients","volume":"97","author":"Naylor","year":"2014","journal-title":"Transplantation"},{"key":"B30-20230816","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"B31-20230816","doi-asserted-by":"crossref","first-page":"E113","DOI":"10.1111\/j.1399-0012.2010.01344.x","article-title":"Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients","volume":"25","author":"Ing","year":"2011","journal-title":"Clin Transplant"},{"key":"B32-20230816","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1600-6143.2006.01557.x","article-title":"Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density","volume":"6","author":"Farmer","year":"2006","journal-title":"Am J Transplant"},{"key":"B33-20230816","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/ajt.12227","article-title":"Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: Results of an open label randomized trial","volume":"13","author":"Amer","year":"2013","journal-title":"Am J Transplant"},{"key":"B34-20230816","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.2013111185","article-title":"Paricalcitol for secondary hyperparathyroidism in renal transplantation","volume":"26","author":"Trillini","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B35-20230816","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/ajt.12911","article-title":"A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism","volume":"14","author":"Evenepoel","year":"2014","journal-title":"Am J Transplant"},{"key":"B36-20230816","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: Biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B37-20230816","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000337526","article-title":"Effects of cinacalcet in renal transplant patients with hyperparathyroidism","volume":"35","author":"Courbebaisse","year":"2012","journal-title":"Am J Nephrol"},{"key":"B38-20230816","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1159\/000304180","article-title":"Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation","volume":"31","author":"Borchhardt","year":"2010","journal-title":"Am J Nephrol"},{"key":"B39-20230816","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ctr.12099","article-title":"Impact of post-kidney transplant parathyroidectomy on allograft function","volume":"27","author":"Parikh","year":"2013","journal-title":"Clin Transplant"},{"key":"B40-20230816","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1600-6143.2008.02327.x","article-title":"Effect of teriparatide on early bone loss after kidney transplantation","volume":"8","author":"Cejka","year":"2008","journal-title":"Am J Transplant"},{"key":"B41-20230816","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00007890-200011270-00028","article-title":"Prevention of bone loss with alendronate in kidney transplant recipients","volume":"70","author":"Kovac","year":"2000","journal-title":"Transplantation"},{"key":"B42-20230816","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1359\/jbmr.2001.16.11.2111","article-title":"Alendronate prevents further bone loss in renal transplant recipients","volume":"16","author":"Giannini","year":"2001","journal-title":"J Bone Miner Res"},{"key":"B43-20230816","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1681\/ASN.V1271530","article-title":"Effect of ibandronate on bone loss and renal function after kidney transplantation","volume":"12","author":"Grotz","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B44-20230816","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/01.TP.0000092523.30277.13","article-title":"Prevalence and treatment of decreased bone density in renal transplant recipients: A randomized prospective trial of calcitriol versus alendronate","volume":"76","author":"Jeffery","year":"2003","journal-title":"Transplantation"},{"key":"B45-20230816","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1523-1755.2003.00816.x","article-title":"Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation","volume":"63","author":"Haas","year":"2003","journal-title":"Kidney Int"},{"key":"B46-20230816","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","article-title":"Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate","volume":"14","author":"Coco","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B47-20230816","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1523-1755.2004.00369.x","article-title":"Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation","volume":"65","author":"Schwarz","year":"2004","journal-title":"Kidney Int"},{"key":"B48-20230816","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.ajkd.2008.11.036","article-title":"Effect of pamidronate on bone loss after kidney transplantation: A randomized trial","volume":"53","author":"Walsh","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B49-20230816","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1097\/TP.0b013e3181dc13d0","article-title":"Open-label trial: Effect of weekly risedronate immediately after transplantation in kidney recipients","volume":"89","author":"Torregrosa","year":"2010","journal-title":"Transplantation"},{"key":"B50-20230816","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00198-010-1197-2","article-title":"Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant","volume":"22","author":"Torregrosa","year":"2011","journal-title":"Osteoporos Int"},{"key":"B51-20230816","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1111\/j.1600-6143.2012.04233.x","article-title":"A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation","volume":"12","author":"Smerud","year":"2012","journal-title":"Am J Transplant"},{"key":"B52-20230816","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1681\/ASN.2011060623","article-title":"Effect of risedronate on bone in renal transplant recipients","volume":"23","author":"Coco","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B53-20230816","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","author":"Jamal","year":"2011","journal-title":"J Bone Miner Res"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201607000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:08Z","timestamp":1786369568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201607000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,15]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11371015","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,15]]}}}